Literature DB >> 8629663

Therapeutic options in patients with hormone-refractory prostate cancer.

N Anand, A Anand.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8629663     DOI: 10.1016/s0002-9343(97)89468-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  1 in total

Review 1.  Suramin's development: what did we learn?

Authors:  Maninderjeet Kaur; Eddie Reed; Oliver Sartor; William Dahut; William D Figg
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.651

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.